Skip to main content
. 2022 Nov 28;2022:4408306. doi: 10.1155/2022/4408306

Table 2.

Descriptive and univariate analyses of sociodemographic, clinical, and disease characteristics of TB patients stratified by first episode and recurrence and multivariate model for recurrent TB (n = 2000).

Factors Descriptive statistics Univariate testa Multivariate test b
Primary (%) Recurrence (%) χ 2 p value p value Odds ratio (95% CI)
Age Median (IQR) 30 (28) 32 (23.5) 0.001 1.011 (1.004–1.017)
BMI Median (IQR) 18.6 (5.2) 18.1 (4.2) 0.06 0.972 (0.942–1.001)
Gender Females 39.5 40.4 0.03 (0.806)
Males 60.5 59.6

Employment status Unemployed 53.9 49.3 1.49 (0.222)
Employed 46.1 50.7

Provincial status Non-Punjabi 25.4 21.1 1.79 (0.182)
Punjabi 74.6 78.9

Marital status Married 62.1 65.5 0.81 (0.369)
Single 37.9 34.5

Socioeconomic status <25000 87.9 81.6 7.12 (0.028)
25001–40000 7.7 11.2
>40000 4.4 7.2

Educational status Higher secondary 32.7 37.2 5.93 (0.052)
Secondary 29.3 21.5
Uneducated 38.0 41.3

BCG vaccinated 28.2 19.7 6.82 (0.009)
HIV positive 0.28 0 0.007 (0.935)
Positive family history 25.2 2.9 0.28 (0.594)
Smokers 21.3 3.2 1.45 (0.228)
Diabetes mellitus 8.3 6.7 0.44 (0.505)
Cardiac vascular diseases 1.7 2.7 0.63 (0.427)
Type of TB EPTB  16.8 9.0 8.44 (0.004)
PTB ∗∗ 83.2 91.0

Xpert MTB-RIF Tested 37.8 29.1 200.65 (<0.001)
Not tested 62.2 70.9

Awareness of TB No 78.7 60.1 37.14 (<0.001)
Yes 21.3 39.9 <0.001 1.906 (1.486–2.437)

AFB sputum Negative 39.0 10.8 175.8 (<0.001) 0.03 0.580 (0.352–0.945)
Nil 30.2 13.5
Positive 30.8 75.8 <0.001 2.384 (1.650–3.536)

Drug resistance DS-TB ∗∗∗ 98.1 61.0
DR-TB ∗∗∗∗ 1.9 39.0 473.3 (<0.001) <0.001 5.615 (4.265–7.386)

a Pearson chi-square test was used for association of factors with cases and a p value of <0.05 was considered significant. b Multivariate regression model was used for the association of risk factors with cases. Only those factors were included in the model whose correlation coefficient is <0.6. extra-pulmonary tuberculosis,  ∗∗ pulmonary tuberculosis, ∗∗∗drug-sensitive tuberculosis, ∗∗∗∗drug-resistant tuberculosis.